These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 9119036)
1. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase A and is regulated by the tissue inhibitors of metalloproteinases. Butler GS; Will H; Atkinson SJ; Murphy G Eur J Biochem; 1997 Mar; 244(2):653-7. PubMed ID: 9119036 [TBL] [Abstract][Full Text] [Related]
2. The recombinant catalytic domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) induces activation of progelatinase A and progelatinase A complexed with TIMP-2. Lichte A; Kolkenbrock H; Tschesche H FEBS Lett; 1996 Nov; 397(2-3):277-82. PubMed ID: 8955363 [TBL] [Abstract][Full Text] [Related]
3. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. Will H; Atkinson SJ; Butler GS; Smith B; Murphy G J Biol Chem; 1996 Jul; 271(29):17119-23. PubMed ID: 8663332 [TBL] [Abstract][Full Text] [Related]
4. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase. Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829 [TBL] [Abstract][Full Text] [Related]
5. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP). Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911 [TBL] [Abstract][Full Text] [Related]
6. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. Sato H; Kinoshita T; Takino T; Nakayama K; Seiki M FEBS Lett; 1996 Sep; 393(1):101-4. PubMed ID: 8804434 [TBL] [Abstract][Full Text] [Related]
7. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Kolkenbrock H; Hecker-Kia A; Orgel D; Ulbrich N; Will H Biol Chem; 1997 Feb; 378(2):71-6. PubMed ID: 9088534 [TBL] [Abstract][Full Text] [Related]
8. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693 [TBL] [Abstract][Full Text] [Related]
9. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system. Jo Y; Yeon J; Kim HJ; Lee ST Biochem J; 2000 Feb; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509 [TBL] [Abstract][Full Text] [Related]
10. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1. Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325 [TBL] [Abstract][Full Text] [Related]
11. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. Bigg HF; Shi YE; Liu YE; Steffensen B; Overall CM J Biol Chem; 1997 Jun; 272(24):15496-500. PubMed ID: 9182583 [TBL] [Abstract][Full Text] [Related]
12. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Ward RV; Hembry RM; Reynolds JJ; Murphy G Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113 [TBL] [Abstract][Full Text] [Related]
13. Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. Okada A; Tomasetto C; Lutz Y; Bellocq JP; Rio MC; Basset P J Cell Biol; 1997 Apr; 137(1):67-77. PubMed ID: 9105037 [TBL] [Abstract][Full Text] [Related]
14. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. Atkinson SJ; Crabbe T; Cowell S; Ward RV; Butler MJ; Sato H; Seiki M; Reynolds JJ; Murphy G J Biol Chem; 1995 Dec; 270(51):30479-85. PubMed ID: 8530478 [TBL] [Abstract][Full Text] [Related]
15. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Fridman R; Toth M; Peña D; Mobashery S Cancer Res; 1995 Jun; 55(12):2548-55. PubMed ID: 7780967 [TBL] [Abstract][Full Text] [Related]
16. Interaction between tissue inhibitor of metalloproteinases-2 and progelatinase A: immunoreactivity analyses. Fujimoto N; Ward RV; Shinya T; Iwata K; Yamashita K; Hayakawa T Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):827-33. PubMed ID: 8611162 [TBL] [Abstract][Full Text] [Related]
17. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. Fernandez-Catalan C; Bode W; Huber R; Turk D; Calvete JJ; Lichte A; Tschesche H; Maskos K EMBO J; 1998 Sep; 17(17):5238-48. PubMed ID: 9724659 [TBL] [Abstract][Full Text] [Related]
18. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. Knäuper V; Will H; López-Otin C; Smith B; Atkinson SJ; Stanton H; Hembry RM; Murphy G J Biol Chem; 1996 Jul; 271(29):17124-31. PubMed ID: 8663255 [TBL] [Abstract][Full Text] [Related]
19. Identification of soluble type of membrane-type matrix metalloproteinase-3 formed by alternatively spliced mRNA. Matsumoto S; Katoh M; Saito S; Watanabe T; Masuho Y Biochim Biophys Acta; 1997 Nov; 1354(2):159-70. PubMed ID: 9396633 [TBL] [Abstract][Full Text] [Related]
20. The propeptide domain of membrane type 1 matrix metalloproteinase is required for binding of tissue inhibitor of metalloproteinases and for activation of pro-gelatinase A. Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S J Biol Chem; 1998 Dec; 273(52):34745-52. PubMed ID: 9856998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]